Editorial: Incretin-based therapies: economic sustainability and health impact in the global management of metabolic syndrome. [PDF]
Provenzani A, Mueller T, Mattina A.
europepmc +1 more source
From Fermented Sugar to Incretin Therapeutics: Reuniting Metabolism and Addiction. [PDF]
Gold MS, Blumenthal DM.
europepmc +1 more source
The incretin-joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies. [PDF]
Papastathopoulou NS +6 more
europepmc +1 more source
Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success. [PDF]
Mallardo M +13 more
europepmc +1 more source
Pharmacological management of obesity: Current landscape and emerging therapies. [PDF]
Atal S, Agrawal C, Gupta R, Sadasivam B.
europepmc +1 more source
GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application. [PDF]
Myśliwczyk D +3 more
europepmc +1 more source
Comments on "Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation" [Letter]. [PDF]
Hou Y, Qiao W, Li R.
europepmc +1 more source
Weight Recurrence After Bariatric Surgery: Incretin-Based Therapies and the Evolving Role of Revisional Surgery. [PDF]
Huerta Díaz LA +3 more
europepmc +1 more source
Adipose Tissue Remodeling Beyond Weight Loss: New Insights Into Incretin-Based Therapies and Bariatric Surgery. [PDF]
Abud GF, de Freitas EC, Stanford KI.
europepmc +1 more source
Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency. [PDF]
Infante M +15 more
europepmc +1 more source

